SCHEMBL3483384

SCHEMBL3483384

CCOC(=O)Cc1cccc(Oc2ccc(Br)cc2CO)c1C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP4F2 P78329 2/20 0.38
CYP4A11 Q02928 2/20 0.38
ALDH1A1 P00352 2/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
NPC1 O15118 2/20 0.36
RAB9A P51151 1/20 0.36
SLC6A4 P31645 2/20 0.35
PKM P14618 1/20 0.35
KDM4E B2RXH2 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1645241 0.79 SLC6A4 (0.42) PTGDR2MEN1KMT2AALDH1A1LMNA
SCHEMBL31053239 0.77 CYP2C9 (0.51) MEN1KMT2AALDH1A1MAPTSLC6A4
SCHEMBL1645250 0.76 SLC6A4 (0.44) PTGDR2MEN1KMT2AALDH1A1LMNA
SCHEMBL1644135 0.76 F10 (0.44) PTGDR2MEN1KMT2ACYP4F2CYP4A11
SCHEMBL31062426 0.76 PKM (0.42) KMT2ACYP4F2CYP4A11MAPTPKM
SCHEMBL11965266 0.75 PTGDR2 (0.43) PTGDR2MEN1KMT2ACYP4F2CYP4A11
SCHEMBL347144 0.74 ABL1 (0.47) PTGDR2MEN1KMT2AALDH1A1LMNA
SCHEMBL1644029 0.73 PTGDR2 (0.41) PTGDR2MEN1KMT2ACYP4F2CYP4A11
SCHEMBL1643221 0.73 SLC6A4 (0.47) PTGDR2MEN1KMT2AALDH1A1LMNA
SCHEMBL1643111 0.72 PTGDR2 (0.43) PTGDR2MEN1KMT2ACYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257536-A2 CYCLIC DIARYL ETHER AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS Amira Pharmaceuticals, Inc. (US) 2010-12-08 EP disclosed
WO-2009102893-A2 CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors AMIRA PHARMACEUTICALS, INC. (US) 2009-08-20 WO disclosed